Beruflich Dokumente
Kultur Dokumente
Version 1.0
2011-01-24
nal von minden GmbH nal von minden GmbH nal von minden GmbH www.nal-vonminden.de
Friedenstraße 32 Carl-Peschken-Str. 9 Laan van Waalhaven 305 info@nal-vonminden.de
D-93053 Regensburg D-47441 Moers NL-2497 Den Haag
DE Gebrauchsanweisung 3
FR Instructions d’utilisation 5
E Instrucciones de uso 6
PL Sposób użcia 8
Symbols 12
Contact 15
nal von minden Drug-Screen® Pipette test
1. Anwendungsbereich 6. Cut-offs (Abkürzung auf den Teststreifen in Klammern)
Einstufige Sandwich-Immunoassays zur qualitativen Bestimmung Parameter Droge/Metabolit** Cut-off
verschiedener Drogen und Drogenmetaboliten im humanen Urin. Der Test (ng/ml)
ist nur für den professionellen Gebrauch vorgesehen (medizinische AMP (Amphetamin)* Amphetamin 1000
Fachkreise). AMP (Amphetamin)* Amphetamin 500
2. Testdurchführung AMP (Amphetamin)* Amphetamin 300
1) Entnehmen Sie den Test der Umverpackung. Kühl gelagerte Tests BAR (Barbiturate) Secobarbital 300
bzw. Urinproben vorher auf Raumtemperatur bringen. BZD (Benzodiazepine)* Oxazepam 300
2) Geben Sie in jede Vertiefung für die Probenaufnahme 3 Tropfen Urin BZD (Benzodiazepine)* Oxazepam 200
(ca. 150 μl Urin). Achten Sie darauf, dass kein Urin direkt auf die BZD (Benzodiazepine)* Oxazepam 100
Membran gelangt. BUP (Buprenorphin) Buprenorphin-β3-D-Glucuronid 10
3) Lesen Sie das Ergebnis nach ca. 5 Minuten ab. COC (Kokain)* Benzoylecgonin 300
COC (Kokain)* Benzoylecgonin 100
Hier je Vertiefung 3 Tropfen COT (Cotinin) Cotinin 200
Urin eintropfen. EDDP (Methadon Metabolit) 2-Ethylidin-1,5-Dimethyl-3,3- 100
FYL (Fentanyl) Fentanyl 10
KET (Ketamin) Ketamin 1000
MDA (Amphetamin) Methylendioxyamphetamin 500
MDMA/XTC (Ecstasy)* 3,4-Methylendioxy- 1000
MDMA/XTC (Ecstasy)* 3,4-Methylendioxy- 500
MET (Methamphetamin)* Methamphetamin 1000
MET (Methamphetamin)* Methamphetamin 500
MET (Methamphetamin)* Methamphetamin 300
MOR 2000 (Morphin/Heroin)* Morphin 2000
MOR 300 (Morphin/Heroin)* Morphin 300
3. Testauswertung
MOR 100 (Morphin/Heroin)* Morphin 100
Im Reaktionsfeld befinden sich die Testzonen der nachzuweisenden MQL (Methaqualon) Metaqualon 300
Substanzen sowie Kontrollzonen (C).
MTD (Methadon) Methadon 300
> Bei einem negativen Ergebnis, also einer drogenfreien Urinprobe, OXY (Oxycodon) Oxycodon 100
erscheinen alle Streifen in der Testzone und alle Streifen in den PCP (Phencyclidin) Phencyclidin 25
Kontrollzonen. PCM (Paracetamol) Paracetamol/Acetaminophen 5000
PPX (Propoxyphen) Norpropoxyphen 300
TCA Trizykl. Antidepressiva Nortriptylin 1000
THC (Marihuana)* 11-nor-Δ9-THC-9-COOH 150
THC (Marihuana)* 11-nor-Δ9-THC-9-COOH 50
THC (Marihuana)* 11-nor-Δ9-THC-9-COOH 25
TML (Tramadol) Tramadol 100
Alle Parameter sind negativ.
* Es werden Teststreifen für die entsprechende Droge geliefert, bei denen
> Bei einem positiven Ergebnis erscheint kein Streifen neben der der „Cut-off“ unterschiedlich hoch ist.
Parameterbezeichnung. Bei Mischkonsum können mehrere Ergebnislinien ** Verbindung, die als Kalibrator zur Einstellung des jeweiligen Cut-Offs
fehlen. Jede Ergebnislinie sollte einzeln betrachtet werden. benutzt wurde.
7. Literatur
Aniline O., Pittes, F. N., Phencyclidine (PCP): A review and perspectives.
CRC Crit. Rev. Toxicol, 1982, 10, 145-177.
Baselt, R.C. Disposition of Toxic Drugs and Chemicals in Man.
Biomedical Publications, Davis, CA, 1982.
Thomas L. eds., Labor und Diagnose, 6. ed., TH-Books
Verlagsgesellschaft, Frankfurt, 2005
Der Parameter Kokain (COC) ist positiv. Urine Testing for Drugs of Abuse, National Institute on Drug. Abuse
(NIDA), Research Monograph 73, 1986.
Ist in den Kontrollregionen (C) kein Streifen erkennbar, so ist z.B. nicht Ellenhorn, M.J. and Barceloux, D.G. Medical Toxicology. Elsevier Science
genügend Urin aufgetragen worden und der Test ist ungültig! Publishing Company, Inc., New YOrk, 1988.
Fed. Register, Department of Health and Human Services, Mandatory
4. Hinweis Guidelines for Federal Workplace Drug Testing Programs, 53, 69,11970-
Die Farbintensität der Streifen auf der Testmembran kann bei den einzelnen 11979, 1988.
Parametern unterschiedlich sein. Nur wenn kein Streifen erscheint, ist der Gilman, A. G., and Goodman, L. S. The Pharmacological Basis of
Test positiv. Positive und unklare Resultate sollten mit einer zweiten Therapeutics, eds. MacMillan Publishing, New York NY, 1980.
analytischen Methode bestätigt werden (z.B. GC/MS). Gorodetzkym, C. W., Detection of Drugs of Abuse in Biological Fluids, in
Buprenorphin wird ab einer Tagesdosis von 2 mg zuverlässig erfasst. Martin WR(ed): Drug Addiction I, New York, Spring - Verlag, 1977.
5. Warnungen und Vorsichtsmaßnahmen Greenblatt, D.J., Shader, R.I. Benzodiazepines in Clinical Practice. New
York: Raven Press, 1974.
Nur für die in vitro Diagnose vorgesehen.
Harvey, R.A., Champe, P.C. Lippincotts Illustrated Reviews.
Gebrauch nur für den Fachkreis bestimmt.
Pharmacology. 91-95, 1992.
Nach Ablauf des Verfalldatums den Test nicht mehr verwenden.
Hofmann F.E., A Handbook on Drug and Alcohol Abuse: The Biomedical
Urinproben können infektiös sein. Deshalb werden saubere Handhabung
Aspects, New York, Oxford University Press, 1983.
und sichere Aufbewahrung von verwendeten Teststreifen in geeigneten
McBay, A. J., Clin. Chem. 33, 33B-40B, 1987.
Laborabfallbehältern empfohlen.
Die Tests bei 2-30°C lagern und nicht einfrieren.
Ref; 2011-01-24 SvM
Test bei beschädigter Schutzverpackung nicht mehr verwenden.
Nach der Entnahme aus der Schutzverpackung Test sofort verwenden
und nicht auf die Saugfläche greifen.
Nur zum Einmalgebrauch.
3
Deutsch
nal von minden Drug-Screen® Pipette test
1. Intended Use 6. Cut-offs
The single-sandwich immunoassays are for the qualitative determination of Parameter Drug / Metabolite** Cut-off
various drugs and drug metabolites in human urine. The test is for (ng/ml)
professional use only (medical professionals). AMP (Amphetamine)* Amphetamine 1000
2. Procedure of the Test AMP (Amphetamine)* Amphetamine 500
AMP (Amphetamine)* Amphetamine 300
1) Remove the test from the packaging. Bring urine samples to room
temperature before testing them. BAR (Barbiturate) Secobarbital 300
2) Transfer 3 drops of urine (about 150 μl) into each sample opening of BZD (Benzodiazepine)* Oxazepam 300
the test cassette. Make sure that the urine does not come into contact BZD (Benzodiazepine)* Oxazepam 200
with other areas of the test. BZD (Benzodiazepine)* Oxazepam 100
3) Read the results after 5 minutes. BUP (Buprenorphine) Buprenorphine-β3-D- 10
COC (Cocain)* Benzoylecgonine 300
COC (Cocain)* Benzoylecgonine 100
Transfer the 3 drops of
urine here. COT (Cotinine) Cotinine 200
EDDP (Methadone 2-Ethylidine-1,5-Dimethyl-3,3- 100
Metabolite ) Diphenylpyrrolidine
FYL (Fentanyl) Fentanyl 10
KET (Ketamine) Ketamine 1000
MDA (Amphetamine) Methylendioxyamphetamine 500
MDMA/ XTC (Ecstasy)* 3,4-Methylendioxy- 1000
MDMA/ XTC (Ecstasy)* 3,4-Methylendioxy- 500
MET (Methamphetamine)* Methamphetamine 1000
MET (Methamphetamine)* Methamphetamine 500
MET (Methamphetamine)* Methamphetamine 300
3. Interpretation of the Results MOR 2000 Morphine 2000
The test zone (T) will detect the presence of the specified drugs in the urine. MOR 300 (Morphine/Heroin)* Morphine 300
The control zone is the area labeled (C) MOR 100 (Morphine/Heroin)* Morphine 100
MQL (Methaqualone) Methaqualone 300
> With a negative result, a drug-free urine sample, a pink stripe will appear
MTD (Methadone) Methadone 300
in test zone (T) as well as a pink strip in the control area (C)
OXY (Oxycodone) Oxycodone 100
PCP (Phencyclidine) Phencyclidine 25
PCM (Paracetamol) Paracetamol/Acetaminophen 5000
PPX (Propoxyphene) Norpropoxyphene 300
TCA (Tricyclic Antidepress.) Nortriptyline 1000
THC (Marihuana)* 11-nor-Δ9-THC-9-COOH 150
THC (Marihuana)* 11-nor-Δ9-THC-9-COOH 50
All of the parameters are negative. THC (Marihuana)* 11-nor-Δ9-THC-9-COOH 25
TML (Tramadol) Tramadol 100
> With a positive result a pink strip will only appear in the control area (C)
* The cut-off level can vary
7. Literature
Aniline O., Pittes, F. N., Phencyclidine (PCP): A review and perspectives.
CRC Crit. Rev. Toxicol, 1982, 10, 145-177.
Baselt, R.C. Disposition of Toxic Drugs and Chemicals in Man.
Biomedical Publications, Davis, CA, 1982.
Thomas L. eds., Labor und Diagnose, 6. ed., TH-Books
The parameter for cocaine (COC) is positive. Verlagsgesellschaft, Frankfurt, 2005
Urine Testing for Drugs of Abuse, National Institute on Drug. Abuse
If no strip appears in the control zone (C) example test is invalid! (NIDA), Research Monograph 73, 1986.
Ellenhorn, M.J. and Barceloux, D.G. Medical Toxicology. Elsevier Science
4. Note Publishing Company, Inc., New YOrk, 1988.
The intensity of the colour stripe can vary as to what parameters are being Fed. Register, Department of Health and Human Services, Mandatory
tested. Only when no strip appears in the test zone than the test is positive. Guidelines for Federal Workplace Drug Testing Programs, 53, 69,11970-
Positive results should be confirmed with another method (GC/MS). 11979, 1988.
Burprenorphine can be reliably detected from a daily dose of 2 mg. Gilman, A. G., and Goodman, L. S. The Pharmacological Basis of
5. Warnings and Precautions Therapeutics, eds. MacMillan Publishing, New York NY, 1980.
Gorodetzkym, C. W., Detection of Drugs of Abuse in Biological Fluids, in
Only to be used for in vitro diagnostics.
Martin WR(ed): Drug Addiction I, New York, Spring - Verlag, 1977.
Only to be used by medical professionals.
Greenblatt, D.J., Shader, R.I. Benzodiazepines in Clinical Practice. New
Do not use the test after the expiry date; the tests are no longer valid.
York: Raven Press, 1974.
Use necessary precautions when handling the urine samples
Harvey, R.A., Champe, P.C. Lippincotts Illustrated Reviews.
Store the tests at 2-30°C, be sure not to freeze. Pharmacology. 91-95, 1992.
Do not use the tests that have damaged packaging. Hofmann F.E., A Handbook on Drug and Alcohol Abuse: The Biomedical
Use test immediately after removal from protective packaging. Aspects, New York, Oxford University Press, 1983.
Tests are good for only 1 use. McBay, A. J., Clin. Chem. 33, 33B-40B, 1987.
4
English
nal von minden Drug-Screen® Pipette test
1. Domaine d’application 6. Cut-offs (Abréviation des paramètres entre parenthèses)
Ce test utilise la méthode en Sandwich-Immunoassays pour la détection Paramètres Drogue/Métabolite** Cut-off
qualitative de drogues et de leurs métabolites dans les urines humaines. Le (ng/ml
test est uniquement prévu à un usage professionnel (milieux spécialisés). AMP (Amphétamine)* Amphétamine 1000
AMP (Amphétamine)* Amphétamine 500
2. Exécution du test
AMP (Amphétamine)* Amphétamine 300
1) Retirer le test de son emballage. Les tests ainsi que les urines
conservés au frais doivent être amenés à température ambiante. BAR (Barbiturique) Secobarbital 300
2) Déposer 3 gouttes d’urine (environ 150 μl d’urine) dans chaque puits. BZD (Benzodiazépine)* Oxazepam 300
Faire attention à ce que l’urine ne rentre pas en contact direct avec la BZD (Benzodiazépine)* Oxazepam 200
membrane. BZD (Benzodiazépine)* Oxazepam 100
3) Lire les résultats après 5 minutes. BUP (Buprenorphine) Buprénorphine-β3-D- 10
COC (Cocaïne)* Benzoylecgonine 300
COC (Cocaïne)* Benzoylecgonine 100
COT (Cotinine) Cotinin 200
EDDP (métabolite de la 2-Ethylidin-1,5-Dimethyl-3,3- 100
Déposer dans le puits 3 Méthadone) Diphenylpyrrolidin
gouttes d’échantillon d’urine. FYL (Fentanyl) Fentanyl 10
KET (Kétamine) Kétamine 1000
MDA (Amphétamine) Méthylendioxyamphétamine 500
MDMA (Ecstasy)* 3,4-Methylèndioxy- 1000
MDMA (Ecstasy)* 3,4-Methylendioxy- 500
MET (Méthamphétamine)* Méthampétamine 1000
MET (Méthamphétamine)* Méthamphétamine 500
MET (Méthamphétamine)* Méthamphétamine 300
3. Interprétation des résultats MOR 2000 Morphine 2000
Au niveau de la zone de réaction se trouvent les zones de test et les zones MOR 300 (Morphine/Héroïne)* Morphine 300
de contrôle. (C). MOR 100 (Morphine/Héroïne)* Morphine 100
MQL (Métaqualone) Métaqualone 300
> Pour un résultat négatif, donc réalisé sur un échantillon d’urine ne
MTD (Méthadone) Méthadone 300
contenant pas de drogue, des lignes apparaîssent dans la zone de test ainsi
que dans la zone de contrôle. OXY (Oxycodon) Oxycodon 100
PCP (Phencyclidine) Phencyclidine 25
PCM (Paracétamol) Paracétamol/Acétaminophène 5000
PPX (Propoxyphène) Norpropoxyphène 300
TCA (antidépresseur Nortriptyline 1000
tricyclique)
THC (Marijuana)* 11-nor-Δ9-THC-9-COOH 150
Tous les paramètres sont négatifs.
THC (Marjuana)* 11-nor-Δ9-THC-9-COOH 50
> Pour un résultat positif, aucune ligne n’apparaîtra à côté du nom du THC (Marjuana)* 11-nor-Δ9-THC-9-COOH 25
paramètre. Pour une consommation mixte, plusieurs lignes de tests peuvent TML (Tramadol) Tramadol 100
être absentes. Chaque ligne de test doit être interprété individuellement. Les tests peuvent être fournis individuellement pour chaque drogue. *Pour
certaines drogues, différents cut-off sont disponibles.
7. Bibliographie
Aniline O., Pittes, F. N., Phencyclidine (PCP): A review and perspectives.
CRC Crit. Rev. Toxicol, 1982, 10, 145-177.
Le paramètre cocaïne (COC) est positif. Baselt, R.C. Disposition of Toxic Drugs and Chemicals in Man.
Biomedical Publications, Davis, CA, 1982.
Si aucune ligne n’apparaît dans la zone de contrôle (C), cela peut provenir Thomas L. eds., Labor und Diagnose, 6. ed., TH-Books
du fait qu’il n’y a pas assez d’urine. Le test est considéré comme non valide. Verlagsgesellschaft, Frankfurt, 2005
Urine Testing for Drugs of Abuse, National Institute on Drug. Abuse
(NIDA), Research Monograph 73, 1986.
4. Indication Ellenhorn, M.J. and Barceloux, D.G. Medical Toxicology. Elsevier Science
L’intensité de la couleur de la bandelette sur la membrane du test peut être Publishing Company, Inc., New YOrk, 1988.
différente selon les paramètres unitaires. Le test est positif seulement quand Fed. Register, Department of Health and Human Services, Mandatory
aucune ligne n’apparaît. Les résultats positifs et douteux devront être Guidelines for Federal Workplace Drug Testing Programs, 53, 69,11970-
confirmés par une deuxième méthode d’analyse (par exemple GC/MS). 11979, 1988.
Gilman, A. G., and Goodman, L. S. The Pharmacological Basis of
La buprénorphine sera détectée à partir d’une dose journalière de 2 Therapeutics, eds. MacMillan Publishing, New York NY, 1980.
mg. Gorodetzkym, C. W., Detection of Drugs of Abuse in Biological Fluids, in
Martin WR(ed): Drug Addiction I, New York, Spring - Verlag, 1977.
5. Précautions et mesures de sécurité
Greenblatt, D.J., Shader, R.I. Benzodiazepines in Clinical Practice. New
Réservé uniquement à une utilisation In-vitro York: Raven Press, 1974.
Réservé à un usage professionnel. Harvey, R.A., Champe, P.C. Lippincotts Illustrated Reviews.
Ne pas utiliser au-delà de la date de péremption. Pharmacology. 91-95, 1992.
Les échantillons d’urines doivent être considérés comme potentiellement Hofmann F.E., A Handbook on Drug and Alcohol Abuse: The Biomedical
infectieux. Les manipuler et procéder à l’élimination selon les règles en Aspects, New York, Oxford University Press, 1983.
vigueur. McBay, A. J., Clin. Chem. 33, 33B-40B, 1987.
Conserver les tests à une température de 2-30°C et ne pas les congeler.
Ne pas utiliser le test si son emballage est endommagé.
Utiliser immédiatement le test après ouverture de son emballage.
5
Français
nal von minden Drug-Screen® Pipette test
1. Previsto 6. Umbrales de detección
Inmunoensayos “Single-sandwich” para la detección cualitativa de diversas Droga Droga de abuso/ droga psicotrópica Umbral
drogas y sus metabolitos en orina humana. Test diseñado únicamente para (Abreviatura)
uso professional. AMP* Anfetamina 300 ng/ml
AMP* Anfetamina 500 ng/ml
2. Procedimiento del Test
AMP* Anfetamina 1.000 ng/ml
1) Extraer el test del envoltorio. Dejar que las muestras alcancen la
BAR Barbitúricos 300 ng/ml
temperatura ambiente antes de ser testadas.
BUP Buprenorfina 10 ng/ml
2) Transferir 3 gotas de la muestra de orina (alrededor de 150 μl) en
cada pocillo del test cassette. Asegurarse de que la orina no entre en BZD Benzodiazepina 100 ng/ml
contacto con ninguna otra área del test. BZD Benzodiazepina 200 ng/ml
3) Leer los resultados pasados 5 minutos. BZD Benzodiazepina 300 ng/ml
COC* Cocaína/ Benzoylecgonina 100 ng/ml
COC* Cocaína/ Benzoylecgonina 300 ng/ml
COT Cotinina 200 ng/ml
EDDP 2- Etilidina -1,5-DiMetyl -3,3- 100 ng/ml
Transferir 3 gotas de Difenylpyrrolidina
orina aquí. FYL Fentanilo 10 ng/ml
KET Ketamina 1.000 ng/ml
MDA Metilenedioxyanfetamina 500 ng/ml
MDMA/XTC* Éxtasis 500 ng/ml
MET* Metanfetamina 300 ng/ml
MET* Metanfetamina 500 ng/ml
MET* Metanfetamina 1.000 ng/ml
MQL Metacualona 300 ng/ml
3. Interpretación de resultados MTD Metadona 300 ng/ml
La zona de test (T) detecta las drogas que puedan encontrarse en la OPI / MOR* Opiáceos/Morfina 100 ng/ml
muestra de orina. La otra es la zona de control (C). OPI / MOR* Opiáceos/Morfina 300 ng/ml
OPI / MOR* Opiáceos/Morfina 2.000 ng/ml
> Cuando el resultado es negativo (muestra libre de drogas), una línea OXY Oxicodona 100 ng/ml
rosa aparecerá tanto en la zona de test (T) como en la zona de control (C). PCP Fenciclidina 25 ng/ml
PCM Paracetamol/Acetaminofeno 5000 ng/ml
PPX Propoxifeno 300 ng/ml
TCA Antidepresivos tricíclicos 1.000 ng/ml
THC* Marihuana, Hachis 25 ng/ml
THC* Marihuana, Hachis 50 ng/ml
THC* Marihuana, Hachis 150 ng/ml
Todos los parámetros son negativos. TML Tramadol 100 ng/ml
* El Umbral ( „Cut-off“) puede variar.
> Cuando el resultado es positivo solo aparecerá una línea rosa en la
7. Bibliografia
zona de control (C).
Aniline O., Pittes, F. N., Phencyclidine (PCP): A review and perspectives.
CRC Crit. Rev. Toxicol, 1982, 10, 145-177.
Baselt, R.C. Disposition of Toxic Drugs and Chemicals in Man.
Biomedical Publications, Davis, CA, 1982.
Thomas L. eds., Labor und Diagnose, 6. ed., TH-Books
Verlagsgesellschaft, Frankfurt, 2005
Urine Testing for Drugs of Abuse, National Institute on Drug. Abuse
El parámetro de COC es positivo. (NIDA), Research Monograph 73, 1986.
Ellenhorn, M.J. and Barceloux, D.G. Medical Toxicology. Elsevier Science
Si no aparece una línea en la zona de control (C) el test se considerará Publishing Company, Inc., New YOrk, 1988.
inválido. Fed. Register, Department of Health and Human Services, Mandatory
Guidelines for Federal Workplace Drug Testing Programs, 53, 69,11970-
11979, 1988.
4. Nota Gilman, A. G., and Goodman, L. S. The Pharmacological Basis of
La intensidad del color de la línea en la zona de test puede variar Therapeutics, eds. MacMillan Publishing, New York NY, 1980.
dependiendo de los parámetros que están siendo testados. El test Gorodetzkym, C. W., Detection of Drugs of Abuse in Biological Fluids, in
solamente es positivo cuando no paraece ninguna línea en la zona de test Martin WR(ed): Drug Addiction I, New York, Spring - Verlag, 1977.
(T). Los resultados positivos deberían ser contrastados mediante un método Greenblatt, D.J., Shader, R.I. Benzodiazepines in Clinical Practice. New
adicional (GC/MS). York: Raven Press, 1974.
Harvey, R.A., Champe, P.C. Lippincotts Illustrated Reviews.
El umbral de detección de la Buprenorfina comienza a una dosis diaria Pharmacology. 91-95, 1992.
de 2 mg. Hofmann F.E., A Handbook on Drug and Alcohol Abuse: The Biomedical
5. Advertencias y precauciones Aspects, New York, Oxford University Press, 1983.
McBay, A. J., Clin. Chem. 33, 33B-40B, 1987.
Sólo para diagnóstico In-vitro.
Sólo para uso por profesionales de la salud.
No utilizar después de la fecha de caducidad
Las muestras de orina pueden ser infecciosas. Manipular todas las
muestras como si se tratara de agentes infecciosos.
Almacenar los test a una temperatura de entre 2-30°. No congelar los
test.
Deshechar el test si el envoltorio se encuentra dañado.
Utilizar el test inmediatamente tras sacarlo del envoltorio protector.
Único uso.
6
Español
nal von minden Drug-Screen® Pipette test
1. Uso Previsto (Abbreviazione)
Il Drug-Screen test cassetta è un test rapido immunocromatografico per la AMP* Amfetamina 300 ng/ml
rilevazione qualitativa di diversi tipi di droghe d’abuso e dei loro metaboliti AMP* Amfetamina 500 ng/ml
nell’urina umana. Il test è destinato unicamente ad uso professionale. AMP* Amfetamina 1.000 ng/ml
BAR Barbiturici 300 ng/ml
2. Procedura del Test
BUP Buprenorfina 10 ng/ml
1) Rimuovere il test dall’involucro. Portare i campioni di urina a
BZD Benzodiazepina 100 ng/ml
temperatura ambiente prima di effettuare il test.
BZD Benzodiazepina 200 ng/ml
2) Aggiungere 3 gocce di urina (circa 150µl di urina) in ogni pozzetto.
BZD Benzodiazepina 300 ng/ml
Fare attenzione affinché l’urina non entri in contatto direttamente con
la membrana. COC* Cocaina/ Benzoilecgonina 100 ng/ml
3) Leggere i risultati dopo 5-10 minuti. COC* Cocaina/ Benzoilecgonina 300 ng/ml
COT Cotinina 200 ng/ml
EDDP 2- Etilidene -1,5-Dimetil - 3,3- 100 ng/ml
Aggiungere 3 gocce di Difenilpirrolidina
urina FYL Fentanile 10 ng/ml
KET Chetamina 1.000 ng/ml
MDA Metilenediossiamfetamina 500 ng/ml
MDMA/XTC* Ecstasy 500 ng/ml
MDMA/XTC* Ecstasy 1.000 ng/ml
MET* Metamfetamina 300 ng/ml
MET* Metamfetamina 500 ng/ml
MET* Metamfetamina 1.000 ng/ml
MQL Metaqualone 300 ng/ml
MTD Metadone 300 ng/ml
3. Interpretazione dei Risultati OPI / MOR* Oppiacei/Morfina 100 ng/ml
La zona del test (T) rivelerà la presenza delle specifiche sostanze nell’urina. OPI / MOR* Oppiacei/Morfina 300 ng/ml
La zona di controllo (C) è l’area etichettata. OPI / MOR* Oppiacei/Morfina 2.000 ng/ml
OXY Ossicodone 100 ng/ml
> Con un risultato negativo appariranno una linea colorata (rosa) nella PCP Feniciclidina 25 ng/ml
banda di rilevazione del test (T) e una linea colorata nell’area di controllo (C). PPX Propoxifene 300 ng/ml
TCA Antidepressivi triciclici 1.000 ng/ml
THC* Marijuana, Hashish 25 ng/ml
THC* Marijuana, Hashish 50 ng/ml
THC* Marijuana, Hashish 150 ng/ml
TML Tramadolo 100 ng/ml
* Il Cut-off può variare.
Tutti i parametri sono negativi 7. Riferimenti Bibliografici
Aniline O., Pittes, F. N., Phencyclidine (PCP): A review and perspectives.
> In caso di risultato positivo, apparirà una sola linea rosa nell’area di
CRC Crit. Rev. Toxicol, 1982, 10, 145-177.
controllo (C).
Baselt, R.C. Disposition of Toxic Drugs and Chemicals in Man.
Biomedical Publications, Davis, CA, 1982.
Thomas L. eds., Labor und Diagnose, 6. ed., TH-Books
Verlagsgesellschaft, Frankfurt, 2005
Urine Testing for Drugs of Abuse, National Institute on Drug. Abuse
(NIDA), Research Monograph 73, 1986.
Ellenhorn, M.J. and Barceloux, D.G. Medical Toxicology. Elsevier Science
Il parametro per la cocaina è positivo. Publishing Company, Inc., New YOrk, 1988.
Fed. Register, Department of Health and Human Services, Mandatory
Se non appare la linea nell’area di controllo (C) il test non è valido. Guidelines for Federal Workplace Drug Testing Programs, 53, 69,11970-
11979, 1988.
Gilman, A. G., and Goodman, L. S. The Pharmacological Basis of
Therapeutics, eds. MacMillan Publishing, New York NY, 1980.
4. Note Gorodetzkym, C. W., Detection of Drugs of Abuse in Biological Fluids, in
L’intensità del colore delle linee per i diversi parametri può variare. Il test si Martin WR(ed): Drug Addiction I, New York, Spring - Verlag, 1977.
considera positivo solo se non compare la linea del test. Risultati positivi Greenblatt, D.J., Shader, R.I. Benzodiazepines in Clinical Practice. New
devono essere ripetuti o confermati con un ulteriore metodo analitico (per es. York: Raven Press, 1974.
GC/MS). Harvey, R.A., Champe, P.C. Lippincotts Illustrated Reviews.
La Buprenorfina è rilevabile con un dosaggio giornaliero di 2 mg o Pharmacology. 91-95, 1992.
superiore. Hofmann F.E., A Handbook on Drug and Alcohol Abuse: The Biomedical
Aspects, New York, Oxford University Press, 1983.
5. Avvertenze e precauzioni McBay, A. J., Clin. Chem. 33, 33B-40B, 1987.
Solo per uso in vitro
Solo per uso professionale
Non utilizzare dopo la data di scadenza
Usare le necessarie precauzioni nel manipolare i campioni di urina
Conservare ad una temperatura compresa tra 2 e 30°C. Non congelare
Non utilizzare il test se l’involucro è danneggiato
Utilizzare il test subito dopo aver aperto l’involucro
Monouso
6. Cutt-off
Droga Droga/ psicotropo Cut-off
7
Italiano
nal von minden Drug-Screen® Pipette test
1. Zastosowanie 6. Cut-off`s (wartości progowe)
Testy kasetowe nal von minden są immunologicznymi badaniami Parametr Narkotyk/metabolit** Cut-
chromatograficznymi do szybkiego wykrywania różnych narkotyków lub off
leków psychotropowych i ich metabolitów w ludzkim moczu. Testy są AMP (Amfetamina)* Amfetamina 1000
przeznaczone tylko do profesjonalnego użytku. AMP (Amfetamina)* Amfetamina 500
AMP (Amfetamina)* Amfetamina 300
2. Przeprowadzenie testu
1) Wyjąć test zanurzeniowy z foliowego opakowania. Przed wykonaniem BAR (Barbituraty) Sekobarbital 300
testu, test, próbka moczu, powinny osiągnąć temperaturę pokojową BZO (Benzodiazepiny)* Oksazepam 300
(15-30°C). BZO (Benzodiazepiny)* Oksazepam 200
2) Zaaplikować 3 krople (ok. 150µl) moczu w otwór na próbkę moczu. BZO (Benzodiazepiny)* Oksazepam 100
Zwrócić uwagę na to, żeby mocz bezpośrednio nie dostał się na BUP (Buprenorfina) Buprenorfin-β3-D-glucuronid 10
membranę. COC (Kokaina)* Benzoilekgonina 300
3) Odczytać wyniki po upływie 5 minut.
COC (Kokaina)* Benzoilekgonina 100
Otwór na próbkę moczu COT (Kotynina)* Kotynina 200
EDDP(Metabolit metadonu) 2-Etylidin-1,5-Dimetyl-3,3- 100
Difenylpyrrolidin
8
Polski
Bromazepam 500
1. Detailed list of cut-offs Chlordiazepoxide 2.500
Clobazam 63
The following structurally related substances resulting from the concentration Clonazepam 1.250
following a positive result. Clorazepat 3.330
Delorazepam 1.250
Amphetamine Desalkflurazepam 400
Amphetamine -Test with Cut-off 300 ng/ml (AMP300). Diazepam 250
Drug Concentration (ng/ml) Estazolam 2.500
D-Amphetamine 300 Flunitrazepam 250
3,4-Methylendioxy-amphetamine Lorazepam 1.250
500
(MDA) Lormetazepam 1.250
3,4-Methylendioxy-methamphetamine >20.000 Midazolam 7.500
(MDMA) Nitrazepam 25.000
L-Amphetamine >50.000 Norchlordiazepoxid 125
Nordiazepam 500
Amphetamine -Test with Cut-off 500 ng/ml (AMP500). Temazepam 125
Drug Concentration (ng/ml) Triazolam 1.250
D-Amphetamine 500
L-Amphetamine 15.000 Benzodiazepine-Test with Cut-off 300 ng/ml (BZD)
(+/-)3,4-methylenedioxyamine (MDA) 700 Drug Concentration (ng/ml)
MDMA 12.000 Oxazepam 300
a-Hydroxyalprazolam 2.500
Amphetamine-Test with Cut-off 1000 ng/ml (AMP1000) Alprazolam 250
Drug Concentration (ng/ml) Bromazepam 625
D-Amphetamine 1.000 Chlordiazepoxid 3.750
L-Amphetamine >50.000 Clobazam 100
D-Methamphetamine >20.000 Clonazepam 2.500
L-Methamphetamine >20.000 Clorazepat 5.000
3,4-Methylendioxyamphetamine (MDA) 2.400 Delorazepam 2.500
3,4-Methylendioxy-methamphetamine Desalkflurazepam 500
>20.000
(MDMA) Diazepam 300
3,4-Methylendioxyethylamphetamine Estazolam 5.000
>100.000
(MDEA) Flunitrazepam 375
Paramethoxyamphetamine (PMA) 1.000 Lorazepam 1.500
Lormetazepam 2.000
Barbiturate Midazolam 10.000
Barbiturat-Test with Cut-off 300 ng/ml (BAR) Nitrazepam 37.500
Drug Concentration (ng/ml) Norchlordiazepoxid 250
Secobarbital 300 Nordiazepam 750
Phenobarbital 300 Temazepam 150
Butalbital 3.000 Triazolam 1.875
Allobarbital 5.000
Alphenal 625 Cocaine
Amobarbital 600 Cocaine-Test with Cut-off 100 ng/ml (COC100)
Aprobarbital 600 Drug Concentration(ng/ml)
Hexobarbital >100.000 Cocaine 3.000
Butabarbital 75 Benzoylecgonine 100
Pentobarbital 300 Ecgonine-Methylester >100.000
Ecgonine >40.000
Buprenorphine
Buprenorphine -Test with Cut-off 10 ng/ml (BUP). Cocaine-Test mit Cut-off 300 ng/ml (COC300)
Drug Concentration (ng/ml) Drug Concentration (ng/ml)
Buprenorphine 10 Cocaine 1.000
Buprenorphine-3- -d-glucuronide 10 Benzoylecgonine 300
Nor-Buprenorphine >1.000 Ecgonine-Methylester >100.000
Nor-Buprenorphine-3- -d-glucuronide >1.000 Ecgonine >40.000
Benzodiazepine Cotinine-Test
Benzodiazepin-Test with Cut-off 100 ng/ml (BZD100) Cotinine-Test mit Cut-off 200 ng/ml (COT)
Drug Concentration (ng/ml) Drug Concentration(ng/ml)
Oxazepam 100 Cotinine 200
a-Hydroxyalprazolam 625 (-)-Nicotine >50.000
Alprazolam 63
Bromazepam 250 EDDP/Methadone-Metabolites
Chlordiazepoxid 1.250 EDDP-Test with Cut-off 100 ng/ml (EDDP)
Clobazam 31 Drug Concentration (ng/ml)
Clonazepam 625 2-ethyliden-1,5-dimethyl-3,3- 100
Clorazepat 1.670 diphenylpyrolidine (EDDP)
Delorazepam 625 Doxylamine >1.000.000
Desalkflurazepam 125 Methadone >10.000
Diazepam 125 Methadol >10.000
Estazolam 1.250
Flunitrazepam 125 Fentanyl-Metabolites
Lorazepam 313 Fentanyl-Test with Cut-off 10 ng/ml (Fentanyl)
Lormetazepam 750 Drug Concentration (ng/ml)
Midazolam 2.500 Fentanyl-Metabolite 10
Nitrazepam 12.500
Norchlordiazepoxid 63 Ketamine
Nordiazepam 250 Ketamine-Test with Cut-off 1000 ng/ml (Ketamine)
Temazepam 63 Drug Concentration (ng/ml)
Triazolam 750 Ketamine 1.000
Norketamine 2.000
Benzodiazepine-Test with Cut-off 200 ng/ml (BZD200) Phencyclidine >10.000
Drug Concentration (ng/ml)
Dextromethorphan 1.000
Oxazepam 200
a-Hydroxyalprazolam 1.250 Lidocaine >100.000
Alprazolam 188 Promethazine 20.000
9
d-Amphetamine >100.000 Mecloqualone 500
Methadone 25.000 3’-Hydroxy methaqualone 500
Methadol 50.000 4’-Hydroxy methaqualone 500
Pethidine 12.500 2’-Hydroxy methaqualone 3.000
Methampetamine 12.500 Amitriptyline 50.000
Carbamazepine 20.000
MDMA >100.000
Nortriptyline 50.000
Phenytoine 40.000
MDA
Primidone 24.000
MDA-Test with Cut-off 500 ng/ml (MDA)
Theophylline 40.000
Drug Concentration (ng/ml)
(+/-)3,4-Methylenedioxyamphetamine 500
Methadone & Derivats
(MDA)
Methadone-Test with Cut-off 300 ng/ml (MTD)
3,4–Methylenedioxyethylamphetamine 300
Drug Concentration (ng/ml)
Methadone 300
MDMA/XTC Methadole 1.000
MDMA-Test with Cut-off 500ng/ml (MDMA/XTC500) 2-Ethyliden-1,5-Dimethyl-3,3- >40.000
Drug Concentration(ng/ml) Diphenylpyrolidine (EDDP)
3,4-Methylendioxy-methamphetamine Doxylamine >40.000
500
(MDMA)
3,4-Methylendioxyamphetamine (MDA) 1.000 Opiate/Morphine
3,4-Methylendioxyethylamphetamine Morphine-Test with Cut-off 100 ng/ml (MOR100).
300
(MDEA) Drug Concentration (ng/ml)
D-Amphetamine >100.000 Morphine 100
D-Methamphetamine >100.000 Codeine 100
Paramethoxyamphetamine (PMA) 5.000 Diacetylmorphine 100
Ethylmorphine 100
MDMA/XTC-Test with Cut-off 1000 ng/ml (MDMA/XTC1000) Hydromorphone 500
Drug Concentration(ng/ml) Hydrocodone 500
3,4-Methylendioxy-methamphetamine Meperidine >100.000
1.000
(MDMA) 6-Monoacetylmorphine 100
3,4-Methylendioxyamphetamine (MDA) 2.000 Morphin-3-β-d-glucuronide 2.000
3,4-Methylendioxyethylamphetamine Oxycodone >20.000
600
(MDEA) Oxymorphone >20.000
D-Amphetamine >100.000 Promethazine >250.000
D-Methamphetamine 100.000 Rifampicin 8.400
L-Methamphetamine >100.000 Thebain 8.400
Trimipramine >20.000
Methamphetamine
Methamphetamine-Test with Cut-off 300 ng/ml (MET300). Morphine-Test with Cut-off 300 ng/ml (MOR300)
Drug Concentration (ng/ml) Drug Concentration (ng/ml)
(+)-Methamphetamine 300 Morphine 300
D-Amphetamine >40.000 Codeine 300
Chloroquine 5.000 Diacetylmorphine (Heroine) 300
(+/-)-Ephedrine >100.000 Ethylmorphine 300
L(-)-Methamphetamine 10.000 Hydromorphone 1.500
Mephentermine 50.000 Hydrocodone 1.500
(+/-)3,4-Methylendioxy- 1.000 Merperidine >100.000
methamphetamine (MDMA) 6-Monoacetylmorphine 300
(+/-)3,4-Methylendioxy- 10.000 Morphin-3- β-d-glucuronide 6.000
ethylamphetamin e(MDEA) Oxycodon >20.000
Procaine 35.000 Oxymorphon >20.000
β-Phenylethylamine 35.000 Promethazin >250.000
Ranitidine 35.000 Rifampicin 25.000
Thebain 2.50
Methamphetamine-Test with Cut-off 500 ng/ml (MET500). Trimipramine >20.000
Drug Concentration (ng/ml)
(+)-Methamphetamine 500 Morphine-Test with Cut-off 2000 ng/ml (MOR2000).
D-Amphetamine >50.000 Drug Concentration (ng/ml)
Chloroquine >50.000 Morphine 2.000
(+/-)-Ephedrine >50.000 Codeine 2.000
L(-)-Methamphetamine >50.000 Diacetylmorphine (Heroine) 2.000
Mephentermin >50.000 Ethylmorphine 600
(+/-)3,4-Methylenedioxymeth- 700 Hydromorphone 15.000
amphetamin (MDMA) Hydrocodone 15.000
Procaine 20.000 Merperidine >100.000
-Phenylethylamine 30.000 6-Monoacetylmorphine 5.000
Ranitidin >50.000 Morphin-3-β-d-glucuronide 10.000
Oxycodon >20.000
Methamphetamine-Test with Cut-off 1000 ng/ml (MET1000) Oxymorphone >20.000
Drug Concentration (ng/ml) Rifampicin >50.000
D-Methamphetamine 1.000 Thebain 20.000
D-Amphetamine >40.000 Morphine 2.000
Chloroquine 10.000
(+/-)-Ephedrine >100.000 Oxycodone
L-Methamphetamine 15.000 Oxycodone-Test with Cut-off 100 ng/ml (OXY).
3,4-Methylendioxy-amphetamine >10.000 Drug Concentration (ng/ml)
(MDA) Oxycodone 100
3,4-Methylendioxy-methamphetamine 2.000 Oxymorphone 500
(MDMA) Codeine >100.000
3,4-Methylendioxy-ethylamphetamine 20.000 Diacetylmorphine (Heroine) >100.000
(MDEA) Ethylmorphine 10.000
Procaine 100.000 Hydrocodone 10.000
Hydromorphone 10.000
Methaqualone Merperidine >100.000
Methaqualone-Test with Cut-off 300 ng/ml (MQL) 6-Monoacetylmorphine >100.000
Drug Concentration (ng/ml) Morphin-3-beta-D-glucuronide >250.000
Methaqualone 300 Thebain >100.000
10
With exception of the respective parameters positive reacting drugs and drug
Phencyclidine metabolites, which are listed above, all below listed compounds react
PCP-Test with Cut-off 25 ng/ml (PCP) negatively up to a concentration of 100 µg/ml.
Drug Concentration(ng/ml)
Phencyclidine 25 Acetaminophene Guaiacol Glyceryl Ether
Tenocyclidine 2.000 Acetone Hämoglobin
Albumin Ibuprofen
Paracetamol Ampicillin (+/-)-Isoproterenol
PCM-Test with Cut-off 5000 ng/ml (PCM) Aspartam Koffein
Drug Concentration (ng/ml) Aspirin Kreatin
Paracetamol 5.000 Atropin Lidocain
Benzocaine L-Phenylephrin
Beta-Phenylethylamine N-Methyl-Ephedrin
Propoxyphene
PPX-Test with Cut-off 300 ng/ml (PPX) (+)-Naproxen ([S]-6-Methoxy--
Drug Concentration (ng/ml) Chinidine Methyl-2-Naphthalenessigsäure)
D-Propoxyphene 300 Chloroquine Oxalsäure
D-Norpropoxyphene 300 Chlorpheniramine Penicillin-G (Benzylpenicillin)
4-Dimethylaminoantipyrine Pheniramin
TCA Dopamin (3-Hydroxytyramin) Phenothiazin
TCA-Test with Cut-off 1000 ng/ml (TCA) (-)-Ephedrine Procain
Drug Concentration(ng/ml) (+/-)-Ephedrine Ranitidin
Nortriptyline 1.000 Ethanol Sulindac
Amitriptyline 1.000 Furosemid Tyramin
Chlorpromazine 3.500 Vitamin C (Ascorbinsäure)
Clomipramine 10.000
Cyclobenzaprine 1.500
Desipramine 500
Diphenyldraminee 20.000
Doxepine 1.000
Imipramine 800
Nordoxepine 1.000
Opipramol 4.000
Protriptylin 3.000
Doxepin 1.000
Perphenazine 25.000
Promazin 200
Promethazin 40.000
Protryptylin 3.000
Trimipramine 2.500
Tramadol
Tramadol-Test with Cut-off 100 ng/ml (Tramadol)
Drug Concentration (ng/ml)
Tramadol 100
N-desmethyl-tramadol 250
O-desmethyl-tramadol 10.000
11
Symbol English Deutsch Français Nederlands Español Italiano
Consult Gebrauchsan- Consulter les Consulte las Consultare le
Gebruiksaanwij
instructions for weisung instructions instrucciones istruzioni per
-zing
use beachten d’utilisation de uso l’uso
CE- Conformité aux Conform
European Conformidad Conformità
Konfirmitäts- normes Europese
Conformity europea europea
kennzeichnung européennes richtlijnen
In vitro Usage In vitro Para uso Per uso
In-vitro-
diagnostic Diagnostic diagnostisch Diagnóstico in Diagnostica in
Diagnostikum
device in vitro gebruik vitro vitro
Catalogue Numéro de Catalogus Número de Numero di
Katalog-Nr.
number catalogue nummer catálogo Catalogo
Lot. No. / Batch
Chargen-Nr. Numéro de lot Lot nummer Número de lote Numero di lotto
code
Contains Contenu Contenido Contenuto
Ausreichend für Geschikt voor
sufficient for suffisant pour suficiente para sufficiente per
”n” Ansätze <n> tests
<n> tests/ ”n” tests <n> ensayos ”n” saggi
Temperatura
Storage Lagerungs- Température Opslag Temperatura di
de
Temperature temperatur de conservation temperatuur conservazione
conservación
Mindesthalt- Date limite Houdbaarheids Fecha de Data di
Expiration Date
barkeitsdatum d’utilisation datum caducidad scadenza
Legal
Hersteller Fabricant Fabrikant Fabricante Fabbricante
Manufacturer
nal von minden GmbH nal von minden GmbH CEOs: S. von Minden,:
Schikanederstraße 2 a
D-93053 Regensburg
Carl-Peschken-Str. 9
D-47441 Moers
R. Meißner, T. Zander
Internet: www.nal-vonminden.de
12
Fon: +49 (941)29010-0 Fon: +49 (2841) 99820-0 E-Mail: info@nal-vonminden.de
Fax: +49 (941) 29010-50 Fax: +49 (2841) 99820-1 FreeFax: (0800) 86 46 336
Notes:
13
Notes:
14
CONTACTS:
www.nal-vonminden.com
info@nal-vonminden.de
France-Team:
France Tel: 0800 915 240
France Fax: 0800 564 720
Swiss Tel: 0800 564 720
Germany-Team: Swiss Fax: 0800 837 476
Regensburg Belgium Tel: 0800 718 82
Tel: +49 (941) 290 10 0 Belgium Fax: 0800 747 07
Fax: +49 (941) 290 10 50 Lux. Tel: 800 211 16
Lux. Fax: 800 261 79
Moers
Tel: +49 (2841) 99820-0 Poland-Team:
Fax: +49 (2841) 99820-1 Tel: +49 (0) 941 290 10 20
Free Tel: 00 800 491 15 95
Fax: +49 (0) 941 290 10 50
Austria-Team: Free Fax: 00 800 491 15 94
Tel: +49 (0) 941 290 10 38
Free Tel: 0800 291 565 Italy-Team:
Fax: +49 (0) 290 10 50 Tel: +49 (0) 941 290 10 34
Free Fax: 0800 298 197 Fax: +49 (0) 941 290 10 50
15
nal von minden GmbH
Carl-Peschken-Straße 9
47441 Moers
Germany
www.nal-vonminden.de
16